Prevention of Interleukin-2 Withdrawal-Induced Apoptosis in Lymphocytes Retrovirally Cotransduced With Genes Encoding an Antitumor T-cell Receptor and an Antiapoptotic Protein-Reference-Cited by-同舟云学术

Prevention of Interleukin-2 Withdrawal-Induced Apoptosis in Lymphocytes Retrovirally Cotransduced With Genes Encoding an Antitumor T-cell Receptor and an Antiapoptotic Protein

Published:2010-09 Issue:7 Volume:33 Page:672-683
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Kalbasi Anusha,Shrimali Rajeev K.,Chinnasamy Dhanalakshmi,Rosenberg Steven A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference30 articles.

1. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens;Dudley;J Clin Oncol,2008

2. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen;Johnson;Blood,2009

3. Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity;Liu;J Immunol,2001

4. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2;Lotze;J Immunol,1985

5. IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells;Duke;Lymphokine Res,1986

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis;Nature Cancer;2023-08-03

2. The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors;Frontiers in Cell and Developmental Biology;2022-04-27

3. TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors;Cancer Research;2016-04-14

4. Reprogramming the tumor microenvironment to enhance adoptive cellular therapy;Seminars in Immunology;2016-02

5. Strategies to Enhance Migration and Persistence of Chimeric Antigen Receptor (CAR)-T Cells into Tumors;Resistance to Targeted Anti-Cancer Therapeutics;2016